Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Oxytocin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44365   clinical trials with a EudraCT protocol, of which   7389   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    107 result(s) found for: Oxytocin. Displaying page 1 of 6.
    1  2  3  4  5  6  Next»
    EudraCT Number: 2010-024649-61 Sponsor Protocol Number: POXY11 Start Date*: 2011-04-05
    Sponsor Name:Radboud University Nijmegen Medical Centre
    Full Title: Pilot study: performance of the Progensa PCA3 test in post-oxytocin urine specimens
    Medical condition: Healthy volunteer trial: intended indication for product is to mobilize prostate cells in urethra for PCA3 test.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10033329 Oxytocin PT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2013-000453-44 Sponsor Protocol Number: NL42746.058.12 Start Date*: 2013-06-19
    Sponsor Name:
    Full Title: The full scope of oxytocinergic influences on the parental brain: Maternal defensiveness and grandparent-child interactions
    Medical condition: There are no medical conditions or diseases under investigation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10033329 Oxytocin PT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-000454-22 Sponsor Protocol Number: NL43068.058.13 Start Date*: 2013-08-21
    Sponsor Name:
    Full Title: (Grand)parenting, oxytocin, and the oxytocin receptor gene: an fMRI and observational study
    Medical condition: There are no medical conditions or diseases under investigation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10033329 Oxytocin PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000298-35 Sponsor Protocol Number: NL60593.028.17 Start Date*: 2017-05-01
    Sponsor Name:Tilburg University
    Full Title: Oxytocin, friendship and dealing with emotions
    Medical condition: There are no medical conditions or disease under investigation.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-002925-30 Sponsor Protocol Number: AGO/2012/003 Start Date*: 2012-09-21
    Sponsor Name:University Ghent
    Full Title: The influence of oxytocin on automatic imitation
    Medical condition: Investigate the influence of oxytocin on automatic imitation
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2022-000156-11 Sponsor Protocol Number: S65914 Start Date*: 2022-02-25
    Sponsor Name:KU Leuven
    Full Title: Oxytocin and the development of attachment: Looking beyond the expected?
    Medical condition: General healthy population children (ages 8 - 13 years old).
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2016-000367-16 Sponsor Protocol Number: 0305070106 Start Date*: 2017-03-23
    Sponsor Name:Radboud University Nijmegen
    Full Title: The effect of oxytocin administration on empathy and emotion recognition in healthy and antisocial adolescents
    Medical condition: We examine the effect of oxytocin administration on empathy and emotion recognition in healthy adolescents and adolescents with antisocial behavior and history of severe psychological trauma
    Disease:
    Population Age: Adolescents, Under 18 Gender: Male
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-005352-25 Sponsor Protocol Number: ML11283 Start Date*: 2015-08-07
    Sponsor Name:KU Leuven
    Full Title: The effect of oxytocin on the training of attachment-related interpretation bias
    Medical condition: General population children (ages 8 - 13 years old)
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002280-10 Sponsor Protocol Number: LBS180319 Start Date*: 2021-04-14
    Sponsor Name:St. Olav's University Hospital
    Full Title: Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial
    Medical condition: Benzodiazepine withdrawal and craving
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022891 - Investigations 10033329 Oxytocin PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2015-003336-12 Sponsor Protocol Number: FatherTrials2015 Start Date*: 2016-03-23
    Sponsor Name:Universiteit Leiden
    Full Title: Father Trials: Hormonal Experiments on Prenatal and Postnatal Parenting
    Medical condition: There are no medical conditions or diseases under investigation
    Disease: Version SOC Term Classification Code Term Level
    18.1 10022891 - Investigations 10047146 Vasopressin LLT
    18.1 10022891 - Investigations 10033329 Oxytocin PT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-000603-12 Sponsor Protocol Number: 80655 Start Date*: 2022-08-05
    Sponsor Name:Radboud University
    Full Title: Oxytocin and reactivity to infant signals in mothers with postpartum depression
    Medical condition: We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004826-40 Sponsor Protocol Number: OXTPRESREL17 Start Date*: 2017-02-17
    Sponsor Name:Department of Psychology, Stockholm University
    Full Title: Effects of oxytocin on suggestibility and consciousness
    Medical condition: There are no medical conditions or diseases under investigation
    Disease: Version SOC Term Classification Code Term Level
    19.1 10022891 - Investigations 10033334 Oxytocin normal PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016613-22 Sponsor Protocol Number: OxyPeP-001 Start Date*: 2010-06-14
    Sponsor Name:PeP-Tonic Medical AB
    Full Title: A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women.
    Medical condition: Vaginal atrophy in postmenopausal women
    Disease: Version SOC Term Classification Code Term Level
    12.1 10047782 Vulvovaginal atrophy LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed) GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-002640-23 Sponsor Protocol Number: APHP200003 Start Date*: 2020-12-14
    Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS
    Full Title: Effect of increased oxytocin doses on the mode of delivery in obese primiparous women with spontaneous labour. A double-blind, randomised, controlled trial
    Medical condition: To compare the rates of caesarean section in obese patients with spontaneous labour between two oxytocin dosage regimens
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006956-36 Sponsor Protocol Number: 2602-619 Start Date*: 2007-02-22
    Sponsor Name:Department og Gynaecology and Obstetric, Randers Hospital
    Full Title: Hvor længe skal oxytocin anvendes ved stimulation af fødsler
    Medical condition: At undersøge nødvendigheden af at fødslen på grund af ve-svækkelse forsat skal stimuleres med oxytocin-drop, når aktiv fødsel er begyndt. Formålet er at få ikke længere fødselsforløb på trods af at...
    Disease:
    Population Age: Gender: Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-006302-28 Sponsor Protocol Number: OXYGENE Start Date*: 2012-07-11
    Sponsor Name:UNIVERSITA' DEGLI STUDI DI PARMA
    Full Title: Dopamine modulation of oxytocin prosocial effects
    Medical condition: HEALTHY VOLUNTEERS. FOR PATIENTS WITH AUTISM OR SCHIZOPHRENIA
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-004134-15 Sponsor Protocol Number: 2013-OX Start Date*: 2014-07-15
    Sponsor Name:Dutch Growth Research Foundation
    Full Title: Intranasal administration of oxytocin in children and young adults with Prader-Willi Syndrome. A randomized, double-blind, placebo-controlled trial. Effects on satiety and food intake, and social b...
    Medical condition: Prader-Willi syndrome
    Disease: Version SOC Term Classification Code Term Level
    17.0 10010331 - Congenital, familial and genetic disorders 10036476 Prader-Willi syndrome PT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002690-22 Sponsor Protocol Number: OXYPEP003 Start Date*: 2013-08-21
    Sponsor Name:PeP-Tonic Medical AB
    Full Title: A pharmacokinetic study of vaginally and intravenously administered oxytocin in postmenopausal women with vaginal atrophy
    Medical condition: Vaginal atrophy in postmenopausal women
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004872 10047782 Vulvovaginal atrophy LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2005-002812-94 Sponsor Protocol Number: LOXY v3 Start Date*: 2005-09-09
    Sponsor Name:North Bristol NHS Trust
    Full Title: Randomised trial of carbetocin versus oxytocin for the prevention of postpartum haemorrhage after caesarean section
    Medical condition: Postpartum haemorrhage after caesarean section
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-000356-33 Sponsor Protocol Number: oxy123 Start Date*: 2013-03-27
    Sponsor Name:Västra Götaland
    Full Title: Delay in labour due to ineffective uterine contractions is still a major problem in modern obstetric care. It is one of the main reasons for the increased rate of operative deliveries, particularly...
    Medical condition: Labor dystocia (LD) also referred to as prolonged labour is a commonly identified problem in modern delivery care with three described possible causes: inefficient uterine action, occiputposterior ...
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004868 10056139 Labour abnormal LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Dec 06 01:25:01 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA